Scientists have found a strong link between the gut microbiome, aging, and liver cancer. New data presented at Digestive Disease Week™ 2026 suggest that restoring a youthful gut community could protect the liver and lower cancer risk.
The research used mice to explore how gut bacteria affect the whole body. Older mice received their own younger gut microbes, and the results were dramatic, especially for the liver.
Young Gut Microbiome Saved Older Mice
Researchers saved fecal samples from eight young mice. As the mice grew older, they gave the stored samples back to the same animals through fecal microbiota transplantation (FMT).
A second group of eight old mice got sterile fecal material as a control. A small set of young mice stayed untouched to serve as a baseline.
At the end of the study, none of the mice that received their youthful microbiome developed liver cancer. In the untreated group, 2 out of 8 mice got liver tumors. The treated mice also showed less inflammation and less liver damage.
"The aging microbiome actively contributes to liver problems and cancer risk, not just reflect aging," said lead researcher Qingjie Li, PhD, from the University of Texas Medical Branch.
Gene Changes Linked to Cancer
After the animal work, the team examined liver tissue. They focused on the MDM2 gene, which is known to play a role in liver cancer.
Younger mice had low levels of the MDM2 protein. Older mice without treatment showed high levels, while the restored‑microbiome mice had reduced MDM2, similar to the young group.
Dr. Li noted that a youthful gut community can reverse many signs of aging, such as inflammation, scar tissue, weak mitochondria, short telomeres, and DNA damage.
From Heart Health to Liver Discoveries
The liver findings emerged while the researchers were studying gut bacteria’s effect on the heart. They saw improvements in heart function, but the liver changes were even stronger, prompting deeper investigation.
To avoid immune reactions, each mouse received its own stored microbiome instead of donor material. This method also makes the concept clearer for future human trials.
While the results are limited to mice, the team hopes to start early human studies soon.